Resultados de la búsqueda 621-630 of 10367 for polycystic ovary syndrome
The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. PLS ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Jacksonville, Fla. The aim of this study is to measure the differences in quality of life and mood of liver transplant recipients in the immediate month post- ...
... disease). This is an investigational study. Radiation therapy is delivered using FDA-approved and commercially available methods. The study doctor can ...
The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
The purpose of this study is to measure how patient anxiety changes using a validated patient reported outcome measure, to measure radiotherapy completion ...
The purpose of this study is to determine how well cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or ...
Los investigadores de Mayo Clinic han creado un nuevo dispositivo que les da a algunas personas que sufren enfermedad de Parkinson y otros trastornos ...
Long Term Clinical Outcomes of Devic's Disease ... ovarian cancer, (7) advanced, unresectable clear ... disease following an attempt to perform ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?